In addition, METTL3/METTL14 and m6A methylation have been reported to play roles in other diseases such as heart failure, viral infection, type 2 diabetes [37], cardiac remodeling, atherosclerosis, congenital heart disease, inflammation, obesity, insulin resistance, adipogenesis, and hypertension [41]. Here, METTL14 is linked to atherosclerosis.